FDA to make Emergency Use Authorization data public for vaccine authorization

United States // 20 November, 2020

The U.S. Food and Drug Administration (FDA) said on 17 November that it would make reviews of all data and information regarding the Emergency Use Authorization (EUA) granted to COVID-19 drugs and vaccines public.

"Today's transparency action is just one of a number of steps we are taking to ensure public confidence in our EUA review process for drugs and biological products, especially any potential COVID-19 vaccines," FDA Commissioner Stephen Hahn said in a statement.

LATEST NEWS

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  • COVID-19 in Eswatini

    Eswatini // 03 December, 2020

    Over 6,000 cases and 120 deaths. Increasing activity...

    COVID-19

  • COVID-19 in Eritrea

    Eritrea // 03 December, 2020

    Over 500 cases. Limited activity...

    COVID-19

  • COVID-19 in Equatorial Guinea

    Equatorial Guinea // 03 December, 2020

    Over 5,000 cases confirmed, and at least 85 deaths. Limited Activity...

    COVID-19

  • COVID-19 in DRC

    Congo DRC // 03 December, 2020

    More than 12,000 cases and over 300 deaths. Limited Activity...

    COVID-19

  • COVID-19 in Cote d'Ivoire

    Cote d'Ivoire // 03 December, 2020

    Over 21,000 cases confirmed. Decreasing activity...

    COVID-19

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
Webinars

Pandemic Information Webinars
(Available to Pandemic Subscribers only)
Register for upcoming events
View/Download previous webinars